SCHEMBL4965170

SCHEMBL4965170

NCC1Oc2cc(F)cc(-c3cc(Cl)ccc3Cl)c2O1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 3/20 0.47
HTR2B P41595 4/20 0.33
HTR2A P28223 3/20 0.33
HTR2C P28335 3/20 0.33
BACE1 P56817 1/20 0.32
ALDH1A1 P00352 2/20 0.31
PDE4D Q08499 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
SLC6A4 P31645 1/20 0.30
S1PR2 O95136 1/20 0.30
S1PR4 O95977 1/20 0.30
S1PR1 P21453 1/20 0.30
S1PR5 Q9H228 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4967249 0.90 AQP1 (0.59) AQP1HTR2BHTR2AHTR2CKDM4E
SCHEMBL4964618 0.89 AQP1 (0.37) AQP1HTR2BHTR2AHTR2CALDH1A1
SCHEMBL4960551 0.86 AQP1 (0.43) AQP1HTR2BHTR2AHTR2CCHRM1
SCHEMBL4960260 0.84 AQP1 (0.41) AQP1HTR2BHTR2AHTR2CCHRM1
SCHEMBL4959837 0.81 AQP1 (0.47) AQP1HTR2BHTR2AHTR2CSLC6A4
SCHEMBL4964730 0.81 AQP1 (0.47) AQP1HTR2BHTR2AHTR2CSLC6A4
SCHEMBL4960764 0.81 AQP1 (0.47) AQP1HTR2BHTR2AHTR2CSLC6A4
SCHEMBL4960191 0.81 AQP1 (0.39) AQP1HTR2BHTR2AHTR2CCHRM1
SCHEMBL14364280 0.80 AQP1 (0.55) AQP1HTR2BHTR2AHTR2CCHRM1
SCHEMBL4961611 0.80 AQP1 (0.38) AQP1HTR2BHTR2AHTR2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871759-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-01-02 EP disclosed
WO-2006116158-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF WYETH (US) 2006-11-02 WO disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof HTR2C, HTR1D, HTR1A AQP1 1697/4885HTR2B 5/4885HTR2A 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.